Evolocumab

ArtNr	HY-P9930-50mg
Hersteller	MedChem Express
CAS-Nr.	1256937-27-5
Menge	50 mg
Quantity options	10 mg 1 mg 25 mg 50 mg 5 mg
Kategorie	Antibodies Primary Antibodies
Typ	Antibody
Specific against	other
Purity	98.40
Citations	[1]Fala L, et, al. Repatha (Evolocumab): Second PCSK9 Inhibitor Approved by the FDA for Patients with Familial Hypercholesterolemia. Am Health Drug Benefits. 2016 Mar;9(Spec Feature):136-9.\|[2]Zhou Q, et al. Protective effect of evolocumab on Müller cells in the rat retina under hyperglycaemic and hypoxic conditions. J Diabetes Complications. 2023 Oct;37(10):108593.\|[3]Safaeian L, et al. Evolocumab, a PCSK9 inhibitor, protects human endothelial cells against H2O2-induced oxidative stress. Arch Physiol Biochem. 2022 Dec;128(6):1681-1686.
Smiles	[Evolocumab]
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	AMG 145
Versandbedingung	Gekühlt
Lieferbar
Manufacturer - Type	Inhibitory Antibodies
Manufacturer - Applications	Metabolism-protein/nucleotide metabolism
Manufacturer - Targets	NF-κB; Ser/Thr Protease; Toll-like Receptor (TLR)
Shipping Temperature	Blue Ice
Storage Conditions	Store at 4°C for 2 years, do not freeze
Molecular Weight	(141.8 kDa)
Product Description	Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab is used in the study of hypercholesterolemia and atherosclerotic cardiovascular disease. Evolocumab binds to circulating PCSK9 protein and inhibits its binding to LDLR. Evolocumab has antioxidant and cytoprotective activities against H2O2-induced oxidative damage to endothelial cells. Evolocumab may also negatively regulate activation of the TLR-4/NF-κB signaling pathway to prevent inflammation[1][2][3].
Manufacturer - Research Area	Cancer; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
Solubility	H2O
Manufacturer - Pathway	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Clinical information	Launched

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

HY-P9930-50mg-safety-datasheet.pdf